{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:44:47Z","timestamp":1785282287265,"version":"3.55.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2013,11,14]],"date-time":"2013-11-14T00:00:00Z","timestamp":1384387200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0079304","type":"journal-article","created":{"date-parts":[[2013,11,14]],"date-time":"2013-11-14T18:01:07Z","timestamp":1384452067000},"page":"e79304","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Development of an Experimental Multiple Serogroups Vaccine for Neisseria meningitidis"],"prefix":"10.1371","volume":"8","author":[{"given":"Valerian B.","family":"Pinto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Burden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyn","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth E.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che-Hung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,11,14]]},"reference":[{"key":"ref1","first-page":"1349","article-title":"Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides. J Exp Med","volume":"129(6)","author":"EC Gotschlich","year":"1969"},{"key":"ref2","first-page":"335","article-title":"Tetravalent meningococcal polysaccharide vaccine groups A, C, Y, W 135: clinical and serological evaluation. J Biol Stand","volume":"10(4)","author":"J Armand","year":"1982"},{"key":"ref3","first-page":"1810","article-title":"Quadrivalent Meningococcal Vaccination of Adults: Phase III Comparison of an Investigational Conjugate Vaccine, MenACWY-CRM, with the Licensed Vaccine, Menactra. Clin Vaccine Immunol","volume":"16(12)","author":"KS Reisinger","year":"2009"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1016\/j.vaccine.2009.07.036","article-title":"Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages","volume":"27(41)","author":"M Br\u00f6ker","year":"2009","journal-title":"Vaccine"},{"key":"ref5","first-page":"657","article-title":"Meningococcal Meningitis: Unprecedented Incidence of Serogroup X-Related Cases in 2006 in Niger. Clin. Infect. Dis","volume":"44","author":"P Boisier","year":"2007"},{"key":"ref6","first-page":"1","article-title":"Emergence of Epidemic <italic>Neisseria meningitidis<\/italic> Serogroup X Meningitis in Togo and Burkina Faso","volume":"6(5)","author":"I Delrieu","year":"2011","journal-title":"Plos one"},{"key":"ref7","first-page":"847","article-title":"Molecular characteristics and epidemiology of Meningococcal carriage, Burkina Faso, 2003. Emerg. Infect. Dis","volume":"13","author":"JE Mueller","year":"2007"},{"key":"ref8","first-page":"619","article-title":"Epidemiology and Risk factors for Serogroup X Meningococcal Meningitis during an Outbreak in Western Kenya, 2005\u20132006. Am. J. Trop. Med. Hyg","volume":"80(4)","author":"DM Mutonga","year":"2009"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1073\/pnas.94.1.271","article-title":"Capsule switching of Neisseria meningitidis. Proc Natl Acad Sci","volume":"94(1)","author":"JS Swartley","year":"1997","journal-title":"USA"},{"key":"ref10","first-page":"2989","article-title":"Evidence of Capsule Switching between Carried and Disease causing Neisseria meningitidis Strains. Infect Immun","volume":"77(7)","author":"AJ Beddek","year":"2009"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis; Implications for vaccine development and pathogenesis","volume":"322","author":"J Finne","year":"1983","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0264-410X(96)00020-5","article-title":"Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine","volume":"(10)","author":"I Claassen","year":"1996","journal-title":"Vaccine 14"},{"key":"ref13","unstructured":"Van Den Dobbelsteen G, Van Dijken H, Hamstra H-J, Ummels R, Van Alphen L, <etal>et al<\/etal>.. (2004) From HexaMen to NonaMen: expanding a multivalent PorA-based meningococcal outer membrane vesicle vaccine. Abstracts of the 14th International Pathogenic Neisseria Conference. Milwaukee WI, Sep 5\u201310, p153."},{"key":"ref14","first-page":"2084","article-title":"Genetically modified L3,7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response. Infect. Immun","volume":"77","author":"VE Weynants","year":"2009"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103(29)","author":"MM Giuliani","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref16","first-page":"2206","article-title":"Outer membrane protein (OMP) based vaccine for Neisseria meningitidis serogroup B. Vaccine","volume":"23(17\u201318)","author":"S Pillai","year":"2005"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1016\/j.vaccine.2010.05.006","article-title":"Design and Evaluation in Mice of a Broadly Protective Meningococcal Group B Native Outer Membrane Vesicle Vaccine","volume":"28","author":"W Zollinger","year":"2010","journal-title":"Vaccine"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"7752","DOI":"10.1016\/j.vaccine.2011.07.124","article-title":"An experimental outer membrane vesicle vaccine from <italic>N. meningitidis<\/italic> serogroup B strains that induces serum bactericidal activity to multiple serogroups","volume":"29","author":"VB Pinto","year":"2011","journal-title":"Vaccine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1086\/597806","article-title":"Meningococcal Factor H\u2013Binding Protein Variants Expressed by Epidemic Capsular Group A, W-135,and X Strains from Africa","volume":"199","author":"PT Beernink","year":"2009","journal-title":"JID"},{"key":"ref20","first-page":"219","article-title":"The lipooligosaccharide immunotype as a virulence determinant in Neisseria meningitidis. Microb. Pathog","volume":"13","author":"DM Jones","year":"1992"},{"key":"ref21","first-page":"873","article-title":"Evolutionary and genomic insights into meningococcal biology. Future Microbiol","volume":"7(7)","author":"HB Bratcher","year":"2012"},{"key":"ref22","first-page":"83","article-title":"Bacterial lipopolysaccharides. Extraction with phenol-water and further application of the procedure","volume":"5","author":"O Westphal","year":"1965","journal-title":"Methods in Carbohydrate Chemistry"},{"key":"ref23","first-page":"5290","article-title":"Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity. Infect. Immun","volume":"62(12)","author":"EE Moran","year":"1994"},{"key":"ref24","first-page":"4070","article-title":"Characterization of native outer membrane vesicles from lpxl mutan strains of Neisseria meningitidis for use in parenteral vaccination. Infect Immun","volume":"73(7)","author":"M Fisseha","year":"2005"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0264-410X(95)00195-7","article-title":"Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate for use in protein-polysaccharide conjugate vaccines and immunological reagents","volume":"26","author":"A Lees","year":"1996","journal-title":"Vaccine"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.vaccine.2008.11.065","article-title":"Preparation and characterization of an immunogenic meningococcal groupA conjugate vaccine for use in Africa","volume":"27","author":"C-H Lee","year":"2009","journal-title":"Vaccine"},{"key":"ref27","first-page":"1798","article-title":"Characterization of an antibody assay for analysis of bactericidal antibody specificity. Clin. Vaccine Immunol","volume":"16(12)","author":"WD Zollinger","year":"2009"},{"key":"ref28","first-page":"98","article-title":"Evaluation of a whole blood cytokine release assay for use in measuring endotoxin activity of group B <italic>Neisseria meningitidis<\/italic> vaccines made from lipid A acylation mutants. Clin Vaccine Immunol","volume":"17(1)","author":"MB Stoddard","year":"2010"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.vaccine.2010.12.039","article-title":"A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted <italic>lpxL1<\/italic> and <italic>synX<\/italic>, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression","volume":"29","author":"PB Keiser","year":"2011","journal-title":"Vacine"},{"key":"ref30","unstructured":"Christensen H, Trotter CL, Hickman M, Edmunds WJ (2010) Modelling the cost-effectiveness of new meningococcal vaccines in England. Abstracts of the 17<sup>th<\/sup> International Pathogenic Neisseria Conference. Banff, Canada, Sep 11\u201316, p41."},{"key":"ref31","first-page":"659","article-title":"Analysis of the bactericidal response to an experimental Neisseria meningitidis vesicle vaccine. Clin Vaccine Immunol","volume":"19(5)","author":"EE Moran","year":"2012"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e66536","DOI":"10.1371\/journal.pone.0066536","article-title":"Mutant native outer membrane vesicles combined with a serogroup A polysaccharide conjugatevaccine for the prevention of meningococcal epidemics in Africa","volume":"8(6)","author":"R Pajon","year":"2013","journal-title":"Plos one"},{"key":"ref33","first-page":"262","article-title":"Bactericidal antibody responses elicited by a meningococcal Outer membrane vesicle vaccine with overexpressed Factor H-binding protein and genetically attenuated endotoxin. J Infect Dis","volume":"198","author":"O Koberling","year":"2008"},{"key":"ref34","first-page":"23","article-title":"Serotype-specific problems associated with pneumococcal conjugate vaccination. Future Microbiol","volume":"3","author":"Hanage William P","year":"2008"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1001\/jama.297.16.1784","article-title":"Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes among Alaska Native Children with High Levels of 7-Valent Pneumococcal Conjugate Vaccine Coverage","volume":"297","author":"J Singleton R","year":"2007","journal-title":"JAMA"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa0800836","article-title":"Effect of pneumococcal conjugate vaccine on pneumococcal meningitis","volume":"360","author":"HE Hsu","year":"2009","journal-title":"NEJM"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0079304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T13:08:43Z","timestamp":1540300123000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0079304"}},"subtitle":[],"editor":[{"given":"Luciana C. C.","family":"Leite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,14]]},"references-count":36,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0079304","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,14]]}}}